Pharmaceuticals - Community Register

  

List of referrals for human medicinal products

Nimesulide

Product name: Nimesulide
Also marketed in the EU under the name(s): Aflogen, Algimesil, Algolider, Algosulid, Algover, Amocetin, Antalgo, Antifloxil, Arencast, Areuma, Aulin, Aulin Beta, Auromelid, Beiond, Bioxidol, Chemisulide, Cliovyl, Delfos, Dimesul, Discorid, Doleside, Dolostop, Dolxtren, Domes, Donulide, Edemax, Edrigyl, Efridol, Elinap, Erlecit, Eudolene, Fansidiol, Fansulide, Fladalgin, Flaminide, Flamisul, Flogostop, Flolid, G-Revm, Gerilide, Guaxan, Idealid, Isartrox, Isodol, Jabasulide, Kartal, Laidor, Lalide, Lasazin, Ledolid, Ledoren, Lemesil, Lidenix, Lidersolv, Liezpat, Lovirem, Melicat, Melimont, Mesulid, Mesupon, Migraless, Min-A-Pon, Mosuolit, Multiformil, Myxina, Naofid, Nerelid, Neuride, Nexen, Niberan, Nide, Nidemol, Nimalge, Nimartin, Nimed, Nimedex, Nimegel, Nimelide, Nimenol, Nimesil, Nimesoral, Nimesul, Nimesulen E, Nimesulene, Nimesulid E UCB, Nimesulida, Nimexan, NIMS, Nisal, Noalgos, Noxalide, Omnibus, Oxetian, Polyfen, Pronidal, Remov, Resulin, Reumalide, Rhemid, Ribantil, Ristolzit, Ritamine, Rolaket, Scaflam, Solving, Specilid, Sudinet, Sulidamor, Sulide, Sulimed, Sulinime, Sulmedil, Teonim, Tranzicalm, Ventor, Vitolide, Volonten, Zulide
INN: Nimesulide
Indication: Treatment of acute pain. Primary dysmenorrhoea. Symptomatic treatment of painful osteoarthritis.
Symptomatic treatment of painful osteoarthritis.
Primary dysmenorrhoea.
Marketing Authorisation Holder: Not applicable

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/04/2004 Referral EMEA/H/A-31/489 (2004)1720 of 26/04/2004
19/10/2009 Referral EMEA/H/A-107/871 (2009)7800 of 16/10/2009
12/03/2010 Corrigendum (2009)7800 corr of 11/03/2010
21/03/2011 Corrigendum